Relationship between selenium and hematologic markers in overweight and anemic patients

Abstract

Anemia is a widespread polyethological disease, one of the possible causes of which is chronic inflammation. In addition, selenium deficiency is also often detected in patients with anemia. In the study, we studied the effect of selenium on iron status in young men with anemia and overweight (since obesity is often associated with chronic inflammation) and the expediency of its use in real clinical practice. The obtained results of treatment of two groups of patients with anemia and overweight who received iron monotherapy and combined therapy with iron and selenium showed that biomarkers of iron status significantly improved with combined treatment with SELENBIO for women than with iron monotherapy (p<0.05). The drug SELENBIO for women has a complex and versatile effect on the human body, has a restorative, immunomodulatory effect, and slows down the aging process due to its antioxidant effect at the cellular level. All components of the drug are physiologically close to the human body and do not disrupt the natural processes occurring in it. The drug SELENBIO for women is highly effective with low toxicity, has a wide range of effects, has a complex harmonizing effect on the body.